Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, announced today its participation in the 37th Annual Piper Sandler Healthcare Conference, December 2-4, 2025, in New York, New York. This invitation-only event will feature more than 400 of the most highly regarded and influential companies across biotechnology, pharmaceuticals, medical technology, diagnostics, life science tools, healthcare services, wellness, and information technology.
Robert L. Gershon, CEO of Convergent Dental, will present on Tuesday, December 2, at 2:10 p.m. EST. In addition to his presentation, Convergent Dental will hold one-on-one meetings that same day with investors and industry professionals, providing insight into Convergent Dental’s latest advancements and strategy for driving the broad-based adoption of Solea.
About Convergent Dental
Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company's flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists and patients can rely on.1 Solea® enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.2
1. Based on report of 1000 procedures performed by Solea users. Documentation on file. 2. Based on 2022 Annual Survey of Solea users. Documentation on file.